The drug licensing body in America has approved the new anti-smoking drug called Chantix, which acts by imitating the effect of nicotine on the body. Research on the effects of this drug on its users showed that almost half of the users were able to completely quit smoking, which has prompted the European regulators to consider its use in United Kingdom.
The drug, which will be marketed in the UK under the name Champix, effectively blocks the withdrawal symptoms. Manufactured by Pfizer, the global pharmaceutical company, the anti-smoking pill will help many give up on the habit.
AdvertisementResearch has indicated that the pill may have some side effects- nausea, but this can be offset when the doses are well spaced out. Statistics have shown that about 12 million adults in the UK smoke and about 114,000 deaths in the UK occur just due to smoking, this pill might just be what the doctor ordered.
PE.coli Infection Affects Child at Nursery Crackdown On Fraud By CFS Helps Scottish Health Service Save Ģ7.4m M
You May Also Like